Evidence map›Paper›PMID 33153494›Full record

ArticleActa neuropathologica communications2020

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.

C Antin, A Tauziède-Espariat, M-A Debily, D Castel, J Grill, M Pagès, O Ayrault, F Chrétien, A Gareton, F Andreiuolo and 2 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. "Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  3. Review
  4. Brain tumor research and treatment · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Rapid intraoperative amplicon sequencing of CNS tumor markers.Computational and structural biotechnology journal · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

C AntinDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
A Tauziède-EspariatDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France. a.tauziede-espariat@ghu-paris.fr.
M-A DebilyUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-Saclay, 94805, Villejuif Cedex, France.
D CastelUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-Saclay, 94805, Villejuif Cedex, France.
J GrillUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, Univ. Paris-Sud, Univ. Paris-Saclay, 94805, Villejuif Cedex, France.
M PagèsDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
O AyraultCNRS UMR, INSERM, Institut Curie, PSL Research University, 91898, Orsay, France.
F ChrétienDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
A GaretonDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
F AndreiuoloDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
E LechaptDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
P VarletDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
Centre Hospitalier Sainte-Anne · FRFHU Neurovasc · FRCentre National de la Recherche Scientifique · FRLaboratoire de Vectorologie et Thérapeutiques Anticancéreuses · FRPrédicteurs moléculaires et nouvelles cibles en oncologieUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AstrocytomaBrain NeoplasmsEpendymomaGlioblastomaGliomaHistonesHumansInfratentorial NeoplasmsOligodendrogliomaOncogene ProteinsSensitivity and SpecificityEZHIP protein, humanH3-3A protein, humanH3C2 protein, humanhistone H3 trimethyl Lys4HistonesOncogene Proteins

Identifiers

PMID33153494
PMCPMC7643397
OpenAlexW3095934771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.